Non-invasive pneumococcal pneumonia in Portugal--serotype distribution and antimicrobial resistance.

There is limited information on the serotypes causing non-invasive pneumococcal pneumonia (NIPP). Our aim was to characterize pneumococci causing NIPP in adults to determine recent changes in serotype prevalence, the potential coverage of pneumococcal vaccines and changes in antimicrobial resistance...

Full description

Bibliographic Details
Main Authors: Andreia N Horácio, Joana P Lopes, Mário Ramirez, José Melo-Cristino, Portuguese Group for the Study of Streptococcal Infections
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4116175?pdf=render
_version_ 1819080413514039296
author Andreia N Horácio
Joana P Lopes
Mário Ramirez
José Melo-Cristino
Portuguese Group for the Study of Streptococcal Infections
author_facet Andreia N Horácio
Joana P Lopes
Mário Ramirez
José Melo-Cristino
Portuguese Group for the Study of Streptococcal Infections
author_sort Andreia N Horácio
collection DOAJ
description There is limited information on the serotypes causing non-invasive pneumococcal pneumonia (NIPP). Our aim was to characterize pneumococci causing NIPP in adults to determine recent changes in serotype prevalence, the potential coverage of pneumococcal vaccines and changes in antimicrobial resistance. Serotypes and antimicrobial susceptibility profiles of a sample of 1300 isolates recovered from adult patients (≥18 yrs) between 1999 and 2011 (13 years) were determined. Serotype 3 was the most frequent cause of NIPP accounting for 18% of the isolates. The other most common serotypes were 11A (7%), 19F (7%), 19A (5%), 14 (4%), 22F (4%), 23F (4%) and 9N (4%). Between 1999 and 2011, there were significant changes in the proportion of isolates expressing vaccine serotypes, with a steady decline of the serotypes included in the 7-valent conjugate vaccine from 31% (1999-2003) to 11% (2011) (P<0.001). Taking together the most recent study years (2009-2011), the potential coverage of the 13-valent conjugate vaccine was 44% and of the 23-valent polysaccharide vaccine was 66%. While erythromycin resistance increased from 8% in 1999-2003 to 18% in 2011 (P<0.001), no significant trend was identified for penicillin non-susceptibility, which had an average value of 18.5%. The serotype distribution found in this study for NIPP was very different from the one previously described for IPD, with only two serotypes in common to the ones responsible for half of each presentation in 2009-2011 - serotypes 3 and 19A. In spite of these differences, the overall prevalence of resistant isolates was similar in NIPP and in IPD.
first_indexed 2024-12-21T19:44:29Z
format Article
id doaj.art-afac9d706e3243c384dbfcf88626f79b
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-21T19:44:29Z
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-afac9d706e3243c384dbfcf88626f79b2022-12-21T18:52:22ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0197e10309210.1371/journal.pone.0103092Non-invasive pneumococcal pneumonia in Portugal--serotype distribution and antimicrobial resistance.Andreia N HorácioJoana P LopesMário RamirezJosé Melo-CristinoPortuguese Group for the Study of Streptococcal InfectionsThere is limited information on the serotypes causing non-invasive pneumococcal pneumonia (NIPP). Our aim was to characterize pneumococci causing NIPP in adults to determine recent changes in serotype prevalence, the potential coverage of pneumococcal vaccines and changes in antimicrobial resistance. Serotypes and antimicrobial susceptibility profiles of a sample of 1300 isolates recovered from adult patients (≥18 yrs) between 1999 and 2011 (13 years) were determined. Serotype 3 was the most frequent cause of NIPP accounting for 18% of the isolates. The other most common serotypes were 11A (7%), 19F (7%), 19A (5%), 14 (4%), 22F (4%), 23F (4%) and 9N (4%). Between 1999 and 2011, there were significant changes in the proportion of isolates expressing vaccine serotypes, with a steady decline of the serotypes included in the 7-valent conjugate vaccine from 31% (1999-2003) to 11% (2011) (P<0.001). Taking together the most recent study years (2009-2011), the potential coverage of the 13-valent conjugate vaccine was 44% and of the 23-valent polysaccharide vaccine was 66%. While erythromycin resistance increased from 8% in 1999-2003 to 18% in 2011 (P<0.001), no significant trend was identified for penicillin non-susceptibility, which had an average value of 18.5%. The serotype distribution found in this study for NIPP was very different from the one previously described for IPD, with only two serotypes in common to the ones responsible for half of each presentation in 2009-2011 - serotypes 3 and 19A. In spite of these differences, the overall prevalence of resistant isolates was similar in NIPP and in IPD.http://europepmc.org/articles/PMC4116175?pdf=render
spellingShingle Andreia N Horácio
Joana P Lopes
Mário Ramirez
José Melo-Cristino
Portuguese Group for the Study of Streptococcal Infections
Non-invasive pneumococcal pneumonia in Portugal--serotype distribution and antimicrobial resistance.
PLoS ONE
title Non-invasive pneumococcal pneumonia in Portugal--serotype distribution and antimicrobial resistance.
title_full Non-invasive pneumococcal pneumonia in Portugal--serotype distribution and antimicrobial resistance.
title_fullStr Non-invasive pneumococcal pneumonia in Portugal--serotype distribution and antimicrobial resistance.
title_full_unstemmed Non-invasive pneumococcal pneumonia in Portugal--serotype distribution and antimicrobial resistance.
title_short Non-invasive pneumococcal pneumonia in Portugal--serotype distribution and antimicrobial resistance.
title_sort non invasive pneumococcal pneumonia in portugal serotype distribution and antimicrobial resistance
url http://europepmc.org/articles/PMC4116175?pdf=render
work_keys_str_mv AT andreianhoracio noninvasivepneumococcalpneumoniainportugalserotypedistributionandantimicrobialresistance
AT joanaplopes noninvasivepneumococcalpneumoniainportugalserotypedistributionandantimicrobialresistance
AT marioramirez noninvasivepneumococcalpneumoniainportugalserotypedistributionandantimicrobialresistance
AT josemelocristino noninvasivepneumococcalpneumoniainportugalserotypedistributionandantimicrobialresistance
AT portuguesegroupforthestudyofstreptococcalinfections noninvasivepneumococcalpneumoniainportugalserotypedistributionandantimicrobialresistance